The legal theory involved in this petition to review lies on the frontiers of antitrust law. See FTC v. Atlantic Richfield Co., No. 76-2250,
The validity of this type of acquisition is a question squarely presented by the order of the Federal Trade Commission (FTC) under review here. Like the Supreme Court in Marine Bancorp.,
I.
BOC International Limited (BOC), formerly known as the British Oxygen Company, has petitioned this court, pursuant to 15 U.S.C. § 21(c), to set aside an FTC order directing BOC, inter alia, to divest itself of its controlling stock interest in Aireo, Inc.
Two months later, the FTC issued a complaint alleging that the acquisition violated the antitrust laws. Id. at 2. Shortly thereafter the Commission obtained a preliminary injunction, pursuant to 15 U.S.C. § 53(b), requiring BOC, inter alia, to maintain Aireo as a separate company during the pendency of expedited administrative proceedings. FTC v. British Oxygen Co.,
II.
The theory on which the FTC based its holding in this case, the actual potential entrant theory, must be distinguished at the outset from the closely related theory, not here involved, addressed to the problem of the “perceived” or “recognized” potential entrant. This latter theory is concerned with a present effect that a company not in an oligopolistic market is having on companies which are in that market. Because the insiders view the outsider as a likely entrant (a competitor “waiting in the wings”), they keep prices and profit margins lower than they would if there were no threat of the outsider entering the market either de novo or via a toehold acquisition of a small firm, a threat that might be realized if prices and profits were higher. When the outsider acquires a large firm in the market, it no longer poses a threat, the “in the wings” effect on prices disappears, and competition is thereby lessened. See Falstaff, supra,
In the instant case, the FTC specifically found, overruling its ALJ, that there was no proof of any “wings” or “fringe” effect of BOC on the American industrial gases market or on prices therein. FTC Op. at 15 n.8. This finding, not challenged here, makes the instant case different from the typical one, in which there is both a perceived and an actual entrant concern, see FTC v. Atlantic Richfield Co., supra, slip op. at 9 n.6; Turner, supra, 78 Harv.L.Rev. at 1362. Here the FTC has in effect conceded that BOC as a potential entrant was having no present procompetitive effect on the relevant market; the Commission’s order is instead grounded entirely on the belief that competition in the American industrial gases market would increase at some time in the future if BOC divests itself of Aireo, see Falstaff, supra,
In determining whether an alleged future effect on competition by itself justifies blocking a present corporate acquisition under the actual potential entrant doctrine, two distinct questions looking to the future must be answered. First, would the firm in question enter de novo or by toehold acquisition
III.
In the instant case, with regard to the first of the two predictions, the FTC made a critical, and controverted, finding:
[A]s of December 1973, there was a “reasonable probability” that BOC would have eventually entered the U.S. industrial gases market by internal expansion, or its equivalent, but for the acquisition of Aireo .
FTC Op. at 27. BOC challenges this finding on the factual ground that it is not supported by “substantial evidence,” 15 U.S.C. § 21(c), and on the legal ground that the standard used—reasonable probability of eventual entry—places a lighter burden on the FTC than is justified by the statute and the purposes of the actual potential entrant doctrine. Because we agree with BOC on the legal question and accordingly set aside the FTC’s order, we need not reach the question whether, if the legal standard used by the FTC had been appropriate, substantial evidence exists in the record to support the result reached.
In Brown Shoe Co. v. United States,
Congress used the words “may be substantially to lessen competition” (emphasis supplied [by the Supreme Court]), to indicate that its concern was with probabilities, not certainties. Statutes existed for dealing with clear-cut menaces to competition; no statute was sought for dealing with ephemeral possibilities. Mergers with a probable anticompetitive effect were to be proscribed by this Act.
There is no indication anywhere in the FTC opinion as to what it meant in using the words “eventual entry,” nor does the record indicate how long a period of time might elapse before BOC could be expected to enter the American industrial gases market de novo or by toehold acquisition. The Commission cited evidence indicating a BOC interest in entering the market since early 1970, but conceded that no entry had been attempted prior to the late 1973 acquisition of Aireo: “Simply because no entry had been effectuated at the time the Aireo opportunity presented itself did not mean that BOC would not have eventually realized its ‘long-term objectives’ of entering the U.S. market—by growth rather than by this major acquisition.” FTC Op. at 27 (emphasis added). In its brief to this court, the FTC entirely ignored BOC’s argument that “[t]he degree of uncertainty in any economic prediction becomes unacceptably high as it is projected farther and farther into the future.” Brief for Petitioners at 82. And at oral argument counsel for the FTC all but conceded that the Commission’s “eventually” standard contained no temporal estimate whatsoever, but rather involved “long range” considerations that might take “decades” to come to fruition. Transcript of Oral Argument at 38, 42, 43.
These FTC statements, combined with what the Commission Omitted to state, together establish the wholly speculative nature of the “eventual entry” test. We hold that such uncabined speculation cannot be the basis of a finding that Section 7 has been violated. As the Supreme Court noted in Marine Bancorp, “the loss of competition ‘which is sufficiently probable and imminent’ is the concern of § 7.”
We emphasize that we are not requiring any exact, precisely calibrated assessment of time of entry. See United States v. Penn-Olin Chemical Co.,
IV.
In an entirely separate aspect of this case, the FTC held that BOC’s acquisition of Aireo would tend to lessen competition in three product lines of medical inhalation anesthetic equipment. BOC’s subsidiaries and Aireo sell such equipment in the United States, so that they are at present actual competitors. This aspect of the case thus has nothing to do with the potential competition doctrine, but instead involves the more widely used Section 7 proscription on “horizontal” mergers, see Brown Shoe Co. v. United States, supra,
This aspect of the case is also of much less overall significance than the industrial gases aspect. Whereas industrial gases account for substantial proportions of both BOC’s and Airco’s total sales, their sales of the three medical product lines at issue amount to less than one per cent of each of their total sales. Compare FTC Op. at 3 with id. at 42. However, their presence in each of these product lines is significant. According to the FTC’s market share data (which are vigorously challenged by BOC), Aireo and BOC are the two largest American manufacturers of anesthesia machines and vaporizers, and Aireo has an 88% share of the anesthesia face mask market. Id. at 42-43.
In addition to challenging the FTC’s market share data, its use of this data, and its definition of relevant product markets, BOC raises two other points that have significance apart from the intrinsic validity or non-validity of the medical equipment holding. First, it alleges that the FTC’s analysis in terms of three equipment sub-markets violated an express understanding, agreed to by FTC complaint counsel, to the effect that inhalation anesthetic equipment would be treated as one large market, and that BOC shaped its defense strategy with this understanding in mind. Second, BOC argues that the Commission did not intend for its finding of a Section 7 violation in the medical equipment lines by itself to justify its order to BOC to divest itself of Aireo and that accordingly, if we overturn the industrial gases holding, as we have, a modified order requiring BOC to divest itself of its subsidiaries involved in the relevant product lines would meet all of the FTC’s remaining concerns, assuming relief were warranted.
We believe that both of these points deserve careful attention; the FTC has apparently not yet had an opportunity to address either one. We have previously held that the FTC lacks authority to consider an issue not litigated before its ALJ. Stanley Works v. FTC,
V.
In a third and final aspect of this case, the FTC ruled that Aireo had “technically” violated the Federal Trade Commission Act, 15 U.S.C. § 45, by “facilitating] an acquisition of stock [by BOC] that violated Section 7 of the Clayton Act.” FTC Op. at 45. It accordingly ordered Aireo to take certain actions “to restore [its] independence from BOC control.” Id. This directive is entirely dependent upon the validity of the re
Order set aside and cause remanded to the Federal Trade Commission for reconsideration of its medical inhalation anesthetic equipment holding in light of BOC’s allegations and the setting aside of the Commission’s industrial gases holding.
Notes
. The petition was actually filed jointly by BOC and several of its subsidiaries, all of which are affected by the FTC order. Because the separate identity of these subsidiaries has no bearing on the principal issues in this case, we adopt the convention of the FTC below of referring to all BOC-related companies under the singular noun “BOC.” See In re British Oxygen Co. (“Findings as to the Facts, Conclusions and Order”), No. 8955, slip op. at 9 (FTC Dec. 8, 1975).
. The FTC’s definition of the relevant domestic industrial gases market is challenged by BOC, but this dispute does not affect our disposition of the instant appeal. The question of market definition is relevant to the issue of how important potential competition from BOC would be to the industrial gases industry, an issue we need not reach here.
. The amicus brief argues that BOC’s acquisition of Aireo should be viewed as a toehold acquisition. Under the generally accepted definitions of such an acquisition, however, see, e.
. The FTC’s opinion mentions an additional source of possible procompetitive BOC influence, derived not from BOC’s future entry into the market but from BOC’s future presence on the fringe of the market. FTC Op. at 16. It is theoretically possible that a firm not currently exerting a fringe effect, as is concededly the case here, id. at 15 n.8, 16, could exert such an effect in the future, regardless of whether it actually entered the market. Mr. Justice Marshall has termed such a firm “a potential perceived potential entrant,” Falstaff, supra,
As its very name suggests, . . . such a firm would be still a further step removed from the exertion of actual, present competitive influence, and the problems of proof are compounded accordingly—particularly in light of the showing of reasonable probability required under § 7.
Id.
When there is no evidence of a past or present fringe effect, it would seem the height of speculation to consider a future fringe effect as a factor independent of the likelihood that the firm in question would actually enter the market. The entirely speculative nature of such a factor is apparent on the face of the Commission’s opinion here:
Although there is no evidence of such disciplining effect in the past, if presents trends continue and supply becomes tight, leading firms may coordinate pricing decisions and areas of specialization . . . The possibility of entry by BOC may become a factor to be reckoned with.
FTC Op. at 16 (emphasis added). No evidence was cited by the Commission as to the likelihood of any of the key variables becoming reality in the future. Accordingly, we will not consider the possibility of a future fringe effect as an independent reason for blocking this acquisition.
. According to Professor Turner:
[T]he problem of proving that the new entrant would have been a substantial competitive factor can be overstated. It is highly likely that a new entrant in . . .a tight oligopoly industry . . . will shake things up a great deal in the process of trying to acquire a substantial market share, even if in the end its inroads are rather modest.
78 Harv.L.Rev. at 1383. The Supreme Court’s apparent emphasis on the procompetitive effects factor in Marine Bancorp.,
. The Court in Brown Shoe Co. v. United States set forth the 1950 amendments to Section 7 of the Clayton Act in footnote 18,
In the course of both the Committee hearings and floor debate, attention was occasionally focused on the issue of whether "possible,” “probable” or “certain” anticompetitive effects of a proposed merger would have to be proven to establish a violation of the Act. . . . The final Senate Report on the question was explicit on the point:
“The use of these words [“may be”] means that the bill, if enacted, would not apply to the mere possibility but only to the reasonable probability of the prescribed [sic] effect. . , . A requirement of certainty and actuality of injury to competition is incompatible with any effort to supplement the Sherman Act by reaching incipient restraints.” S.Rep. No. 1775, 81st Cong., 2d Sess. 6. See also 51 Cong.Rec. 14464 (remarks of Senator Reed).
370 U.S. at 323 n.39,82 S.Ct. at 1522 .
. Because of the predictive or probabilistic nature of the entire actual potential entrant doctrine, Professor Turner has argued that a higher standard of proof regarding entry of the firm is appropriate when, as is the case here, “the sole alleged anticompetitive consequence of a merger is the loss of what would have been a new entrant,” 78 Harv.L.Rev. at 1386 (emphasis in original). The standard suggested is one of certainty, id., or at least of “clear proof that the firm would in fact have entered—an admittedly rare case, and one bound to become even less frequent if this rule were adopted,” id. at 1384. Turner’s test has apparently been adopted by the Fourth Circuit, FTC v. Atlantic Richfield Co., No. 76-2250,
. The Court in United States v. Continental Can Co.,
The effect on competition in a particular market through acquisition of another company is determined by the nature or extent of that market and by the nearness of the absorbed company to it, that company’s eagerness to enter that market, its resourcefulness, and so on.
Id. at 660,
